GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women's health and somatic oncology diagnostic testing and screening products.
Símbolo de cotizaciónWGSWW
Nombre de la empresaGeneDx Holdings Corp
Fecha de salida a bolsaSep 04, 2020
Director ejecutivoMs. Katherine A. Stueland
Número de empleados- -
Tipo de seguridadCompany Warrant
Fin del año fiscal- -
Dirección333 Ludlow Street
CiudadSTAMFORD
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal06902
Teléfono18887291206
Sitio Webhttps://sema4.com/
Símbolo de cotizaciónWGSWW
Fecha de salida a bolsaSep 04, 2020
Director ejecutivoMs. Katherine A. Stueland
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos